Literature DB >> 22267836

Novel avenues for cell therapy in acute myocardial infarction.

David M Leistner, Andreas M Zeiher.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22267836     DOI： 10.1161/CIRCRESAHA.111.260281

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

1.  The challenges of autologous cell therapy: systemic anti-thrombotic therapies interfering with serum coagulation may disable autologous serum-containing cell products for therapeutical use.

Authors:  Florian H Seeger; Tina Rasper; Halvard Bönig; Birgit Assmus; Andreas M Zeiher; Stefanie Dimmeler
Journal:  J Cardiovasc Transl Res       Date:  2014-09-13       Impact factor: 4.132

2.  Aerobic interval training attenuates mitochondrial dysfunction in rats post-myocardial infarction: roles of mitochondrial network dynamics.

Authors:  Hong-Ke Jiang; You-Hua Wang; Lei Sun; Xi He; Mei Zhao; Zhi-Hui Feng; Xiao-Jiang Yu; Wei-Jin Zang
Journal:  Int J Mol Sci       Date:  2014-03-26       Impact factor: 5.923

3.  Effect of Training with or without Ziziphus Jujuba Extract on Cardiokines in Heart Tissue of Myocardial Infarcted Rats.

Authors:  Mahshid Hosseini; Effat Bambaeichi; Hadi Sarir; Mehdi Kargarfard
Journal:  Int J Prev Med       Date:  2019-06-07

4.  Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.

Authors:  Guillaume Lamirault; Sophie Susen; Virginie Forest; Caroline Hemont; Angelo Parini; Philippe Le Corvoisier; Christophe Piot; Marie-Jeanne Richard; Béatrice Delasalle; Hélène Rouard; Catherine Sportouch; Virginie Persoons; Eric Van Belle; Jérôme Roncalli; Patricia Lemarchand
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.